Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Phase 1 Cancer Trials

Sarasota, Florida

Phase 1 cancer trials in Sarasota, FL

45 Phase 1 cancer studies are recruiting participants at sites in Sarasota as of November 17, 2026, according to ClinicalTrials.gov. Phase 1 Cancer Trials can help you understand your options and connect with a study team.

Call (888) 927-9038
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Sarasota at a glance

Breast cancer studies recruiting in Sarasota

Basic details from each study's public record (the 30 most recently updated of 45). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Stemline Therapeutics, Inc.
    Study site
    Florida Cancer Specialists & Research Institute (FCS) - Sarasota
    Registry record
    NCT06638307 · updated
  2. A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    IDEAYA Biosciences
    Study site
    Florida Cancer Specialists
    Registry record
    NCT07503808 · updated
  3. A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    NiKang Therapeutics, Inc.
    Study site
    SCRI Florida Cancer Specialists - Sarasota
    Registry record
    NCT07029399 · updated
  4. A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Compass Therapeutics
    Study site
    Florida Cancer Specialists - Sarasota
    Registry record
    NCT06150664 · updated
  5. A Study of JNJ-101684362 (HLD-0117) in Patients With Metastatic Breast Cancer

    • Phase 1
    • Ages 18 and older
    • Female participants
    Sponsor
    Janssen Research & Development, LLC
    Study site
    Florida Cancer Specialists
    Registry record
    NCT07524855 · updated
  6. A Phase 1 Study of IM-1617 in Participants With Advanced Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Immunome, Inc.
    Study site
    Florida Cancer Specialists & Research Institute - Sarasota Cattlemen
    Registry record
    NCT07578571 · updated
  7. Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    AbbVie
    Study site
    Florida Cancer Specialists- Sarasota Cattlemen /ID# 261569
    Registry record
    NCT06084481 · updated
  8. First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Accent Therapeutics
    Study site
    Florida Cancer Specialists
    Registry record
    NCT06799065 · updated
  9. Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Olema Oncology, Inc.
    Study site
    Florida Cancer Specialists
    Registry record
    NCT06784193 · updated
  10. AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Avacta Life Sciences Ltd
    Study site
    Florida Cancer Specialists and Research Institute
    Registry record
    NCT07454642 · updated
  11. Study of AVZO-021 in Patients With Advanced Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Avenzo Therapeutics, Inc.
    Study site
    Avenzo Therapeutics Recruiting Site
    Registry record
    NCT05867251 · updated
  12. A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Angiex, Inc.
    Study site
    Florida Cancer Specialist
    Registry record
    NCT06440005 · updated
  13. A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer

    • Phase 1
    • Ages 21 and older
    • All sexes
    Sponsor
    MBQ Pharma
    Study site
    Florida Cancer Specialists / Sarah Cannon Research Institute / SCRI
    Registry record
    NCT06075810 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Sarasota, FL on ClinicalTrials.gov.

Lung cancer studies recruiting in Sarasota

  1. A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 to 99
    • All sexes
    Sponsor
    Erasca, Inc.
    Study site
    Florida Cancer Specalists
    Registry record
    NCT06983743 · updated
  2. A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Kestrel Therapeutics, Inc.
    Study site
    Florida Cancer Specialists
    Registry record
    NCT07458347 · updated
  3. SI-B036-ST-101 in Advanced/Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    SystImmune Inc.
    Study site
    Florida Cancer Specialists Sarasota
    Registry record
    NCT07857616 · updated
  4. A Study of ZL-1310 in Subjects With Small Cell Lung Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Zai Lab (Shanghai) Co., Ltd.
    Study site
    Sarah Cannon Research Institute
    Registry record
    NCT06179069 · updated
  5. AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

    • Phase 1/2
    • Ages 18 to 75
    • All sexes
    Sponsor
    Avenzo Therapeutics, Inc.
    Study site
    Avenzo Therapeutics Recruiting Site
    Registry record
    NCT07038343 · updated
  6. KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Kura Oncology, Inc.
    Study site
    Florida Cancer Specialists
    Registry record
    NCT06026410 · updated
  7. A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    BioNTech SE
    Study site
    Florida Cancer Specialists
    Registry record
    NCT07070232 · updated
  8. Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Revolution Medicines, Inc.
    Study site
    Florida Cancer Specialists
    Registry record
    NCT06128551 · updated
  9. A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Blueprint Medicines Corporation
    Study site
    Florida Cancer Specialists & Research Institute - Sarasota
    Registry record
    NCT07629960 · updated
  10. A Study of IDP-001 in Advanced or Metastatic Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    InduPro, Inc.
    Study site
    Florida Cancer Specialists
    Registry record
    NCT07602842 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Sarasota, FL on ClinicalTrials.gov.

Prostate cancer studies recruiting in Sarasota

  1. A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer

    • Phase 1
    • Ages 18 and older
    • Male participants
    Sponsor
    Janssen Research & Development, LLC
    Study site
    Florida Cancer Specialists
    Registry record
    NCT05818683 · updated
  2. Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

    • Phase 1/2
    • Ages 18 and older
    • Male participants
    Sponsor
    Janssen Research & Development, LLC
    Study site
    Florida Cancer Specialists
    Registry record
    NCT06800313 · updated
  3. A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer

    • Phase 1
    • Ages 18 and older
    • Male participants
    Sponsor
    Janssen Research & Development, LLC
    Study site
    Florida Cancer Specialists
    Registry record
    NCT07082920 · updated
  4. A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Janssen Research & Development, LLC
    Study site
    Florida Cancer Specialists
    Registry record
    NCT07319871 · updated
  5. A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer

    • Phase 1
    • Ages 18 and older
    • Male participants
    Sponsor
    Janssen Research & Development, LLC
    Study site
    Florida Cancer Specialists & Research Institute
    Registry record
    NCT07746713 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Sarasota, FL on ClinicalTrials.gov.

Melanoma studies recruiting in Sarasota

  1. MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma

    • Phase 1/2
    • Ages 18 to 90
    • All sexes
    Sponsor
    Perspective Therapeutics
    Study site
    Sarasota Memorial Hospital
    Registry record
    NCT05655312 · updated

Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Sarasota, FL on ClinicalTrials.gov.

Lymphoma studies recruiting in Sarasota

  1. A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    Florida Cancer Specialists - Sarasota
    Registry record
    NCT07226843 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Sarasota, FL on ClinicalTrials.gov.

Ask about studies near Sarasota

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Florida

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.

Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-9038

or send a short form

How should we reach you?

Call